ConductScience.org, home

Paper19716319

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.

Kawai T and 9 others. J Diabetes Complications, 2010. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine. Papers, record 19716319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19716319

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
PubMed
Journal
J Diabetes Complications
PubMed
Year
2010
PubMed
Publication types
Controlled Clinical Trial, Journal Article, Multicenter Study
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawai TToshihide
2Takei IIzumi
3Tokui MMikiya
4Funae OOsamu
5Miyamoto KKazunori
6Tabata MMitsuhisa
7Hirata TTakumi
8Saruta TTakao
9Shimada AAkira
10Itoh HHiroshi

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aldehyde ReductaseMajor topic
Diabetes Mellitus, Type 2Major topic
Diabetic NeuropathiesMajor topic
LysineMajor topic
Peripheral Nervous System DiseasesMajor topic
RhodanineMajor topic
ThiazolidinesMajor topic
Enzyme Inhibitors
Female
Glycation End Products, Advanced
Humans
Male
Middle Aged
Neural Conduction
Sural Nerve
Tibial Nerve

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
41471031Enhanced Ocular Delivery of Epalrestat Using Nanostructured Lipid Carrier Laden Soft Contact Lens.Pharmaceutics2025https://conductscience.org/library/papers/41471031PubMed
40002826Crumbling Pathogenesis and Biomarkers for Diabetic Peripheral Neuropathy.Biomedicines2025https://conductscience.org/library/papers/40002826PubMed
38185272Aldose reductase is a potential therapeutic target for neurodegeneration.Chem Biol Interact2024https://conductscience.org/library/papers/38185272PubMed
37082769Impact of obstructive sleep apnea syndrome on peripheral nerves and the effect of continuous positive airway pressure: a prospective observational case series.Postep Psychiatr Neurol2021https://conductscience.org/library/papers/37082769PubMed
36421725Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke.Biomolecules2022https://conductscience.org/library/papers/36421725PubMed
35955863Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG).Int J Mol Sci2022https://conductscience.org/library/papers/35955863PubMed
33949936Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?Curr Diabetes Rev2022https://conductscience.org/library/papers/33949936PubMed
32832011Understanding Diabetic Neuropathy: Focus on Oxidative Stress.Oxid Med Cell Longev2020https://conductscience.org/library/papers/32832011PubMed
32809100Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.Handb Exp Pharmacol2021https://conductscience.org/library/papers/32809100PubMed
31890342Study on degradation kinetics of epalrestat in aqueous solutions and characterization of its major degradation products under stress degradation conditions by UHPLC-PDA-MS/MS.J Pharm Anal2019https://conductscience.org/library/papers/31890342PubMed
31787891Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.Front Aging Neurosci2019https://conductscience.org/library/papers/31787891PubMed
31636082Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.Dis Model Mech2019https://conductscience.org/library/papers/31636082PubMed
31231498Vitamin D suppresses cellular pathways of diabetes complication in liver.Iran J Basic Med Sci2019https://conductscience.org/library/papers/31231498PubMed
30805403The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy.Rep Biochem Mol Biol2019https://conductscience.org/library/papers/30805403PubMed
29731703Metabolic Syndrome and Neuroprotection.Front Neurosci2018https://conductscience.org/library/papers/29731703PubMed
28659153Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).Lipids Health Dis2017https://conductscience.org/library/papers/28659153PubMed
27306206Iridoids are natural glycation inhibitors.Glycoconj J2016https://conductscience.org/library/papers/27306206PubMed
27073391Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.Neural Regen Res2016https://conductscience.org/library/papers/27073391PubMed
25821809Antioxidant strategies in the management of diabetic neuropathy.Biomed Res Int2015https://conductscience.org/library/papers/25821809PubMed
24634591Advanced glycation end products and diabetic complications.Korean J Physiol Pharmacol2014https://conductscience.org/library/papers/24634591PubMed

See all 23 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKR1A110327PubTator's text mininghttps://conductscience.org/library/genes/10327NCBI Gene
AKR1B1231PubTator's text mininghttps://conductscience.org/library/genes/231NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19716319

GET https://conductscience.org/api/papers/v1/19716319/cited_by?page=2